1-(4-Piperidyl)piperazine - CAS 142013-66-9
Catalog: |
BB009283 |
Product Name: |
1-(4-Piperidyl)piperazine |
CAS: |
142013-66-9 |
Synonyms: |
1-(4-piperidinyl)piperazine; 1-piperidin-4-ylpiperazine |
IUPAC Name: | 1-piperidin-4-ylpiperazine |
Description: | 1-(4-Piperidyl)piperazine (CAS# 142013-66-9 ) is a useful research chemical. |
Molecular Weight: | 169.27 |
Molecular Formula: | C9H19N3 |
Canonical SMILES: | C1CNCCC1N2CCNCC2 |
InChI: | InChI=1S/C9H19N3/c1-3-10-4-2-9(1)12-7-5-11-6-8-12/h9-11H,1-8H2 |
InChI Key: | ZHYYBDZASCMDMP-UHFFFAOYSA-N |
Boiling Point: | 275.3 °C at 760 mmHg |
Density: | 0.997 g/cm3 |
MDL: | MFCD11518985 |
LogP: | 0.23910 |
GHS Hazard Statement: | H303 (100%): May be harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-110965374-A | Environment-friendly chlorine-resistant color fixing agent and preparation method thereof | 20191220 |
CN-110143995-A | Azacyclo- replaces 18 β-Enoxolone derivative and its preparation and application | 20190603 |
US-2020352917-A1 | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders | 20190506 |
WO-2020216371-A1 | Egfr inhibitor and application thereof | 20190426 |
WO-2020207260-A1 | Cdk inhibitor and application thereof | 20190408 |
PMID | Publication Date | Title | Journal |
21324704 | 20110301 | Discovery of novel (4-piperidinyl)-piperazines as potent and orally active acetyl-CoA carboxylase 1/2 non-selective inhibitors: F-Boc and triF-Boc groups are acid-stable bioisosteres for the Boc group | Bioorganic & medicinal chemistry |
20537533 | 20100701 | Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors | Bioorganic & medicinal chemistry letters |
19853443 | 20091201 | (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors | Bioorganic & medicinal chemistry letters |
15084128 | 20040422 | Bisguanidine, bis(2-aminoimidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation | Journal of medicinal chemistry |
Complexity: | 126 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 169.157897619 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 169.157897619 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 27.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS